Cargando…
A Novel Imidazopyridine Derivative Exhibits Anticancer Activity in Breast Cancer by Inhibiting Wnt/β‑catenin Signaling
BACKGROUND: Breast cancer exhibits poor prognosis and high relapse rates following chemotherapy therapeutics. Thus, this study aims to develop effective novel agents regulating the core molecular pathway of breast cancer such as Wnt/β-catenin signaling. METHODS: The present study screened a novel in...
Autores principales: | He, Liu-Jun, Yang, Dong-Lin, Chen, He-Ying, Huang, Jiu-Hong, Zhang, Ya-Jun, Qin, Hong-Xia, Wang, Juan-Li, Tang, Dian-Yong, Chen, Zhong-Zhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553630/ https://www.ncbi.nlm.nih.gov/pubmed/33116593 http://dx.doi.org/10.2147/OTT.S266752 |
Ejemplares similares
-
A Novel Imidazopyridine Derivative Exerts Anticancer Activity by Inducing Mitochondrial Pathway-Mediated Apoptosis
por: Wang, Juanli, et al.
Publicado: (2020) -
Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells
por: Yu, Shubin, et al.
Publicado: (2018) -
Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β-catenin signaling
por: Sun, Qi, et al.
Publicado: (2019) -
Synthesis of New Imidazopyridine Nucleoside Derivatives Designed as Maribavir Analogues
por: Papadakis, Georgios, et al.
Publicado: (2020) -
Substituted imidazopyridines as potent inhibitors of HCV replication()
por: Vliegen, Inge, et al.
Publicado: (2009)